Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guarneri

Showing results (1361-1370 of 1,433) with videos related to

Pageof 144
Sort By:
Dermatology and Therapy|June 9, 2026
Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective StudyLuciano Ibba, Sara Di Giulio, Piergiorgio Malagoli, et al.
Italian Journal of Dermatology and Venereology|March 9, 2022
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasisPaolo Gisondi, Maria C Fargnoli, Paolo Amerio, et al.
BMC Medicine|November 22, 2019
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trialMaria Vittoria Dieci, Giancarlo Bisagni, Alba A Brandes, et al.
Dermatology and Therapy|July 1, 2022
Update on the Management of Pediatric Psoriasis: An Italian ConsensusKetty Peris, Anna Belloni Fortina, Luca Bianchi, et al.
Dermatology and Therapy|September 24, 2024
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World EvidencePiergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Gastroenterology|April 16, 2018
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral AgentsVincenza Calvaruso, Giuseppe Cabibbo, Irene Cacciola, et al.
Therapeutic Advances in Medical Oncology|December 22, 2023
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitorsEmma Zattarin, Luigi Mariani, Alice Menichetti, et al.
Cell|April 2, 2026
A 3D morphogenetic blueprint for metastatic outgrowth in breast cancerRobin Caire, Roberta Bordo, Francesca Zanconato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2024
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient TumorsBrian M Slomovitz, David Cibula, Weiguo Lv, et al.
Tumori|December 15, 2025
Letrozole for hormone receptor-positive low-grade ovarian cancer: Preliminary toxicity results of a phase III trialAlessio Carbone, Elena Biagioli, Vanda Salutari, et al.
Pageof 144

Showing results (1361-1370 of 1,433) with videos related to

Sort By:
Pageof 144
Dermatology and Therapy|June 9, 2026
Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective StudyLuciano Ibba, Sara Di Giulio, Piergiorgio Malagoli, et al.
Italian Journal of Dermatology and Venereology|March 9, 2022
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasisPaolo Gisondi, Maria C Fargnoli, Paolo Amerio, et al.
BMC Medicine|November 22, 2019
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trialMaria Vittoria Dieci, Giancarlo Bisagni, Alba A Brandes, et al.
Dermatology and Therapy|July 1, 2022
Update on the Management of Pediatric Psoriasis: An Italian ConsensusKetty Peris, Anna Belloni Fortina, Luca Bianchi, et al.
Dermatology and Therapy|September 24, 2024
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World EvidencePiergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Gastroenterology|April 16, 2018
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral AgentsVincenza Calvaruso, Giuseppe Cabibbo, Irene Cacciola, et al.
Therapeutic Advances in Medical Oncology|December 22, 2023
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitorsEmma Zattarin, Luigi Mariani, Alice Menichetti, et al.
Cell|April 2, 2026
A 3D morphogenetic blueprint for metastatic outgrowth in breast cancerRobin Caire, Roberta Bordo, Francesca Zanconato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2024
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient TumorsBrian M Slomovitz, David Cibula, Weiguo Lv, et al.
Tumori|December 15, 2025
Letrozole for hormone receptor-positive low-grade ovarian cancer: Preliminary toxicity results of a phase III trialAlessio Carbone, Elena Biagioli, Vanda Salutari, et al.
Pageof 144